July 4, 2022 | HealthClot

Approved and emerging CAR-Ts in multiple myeloma

By HealthClot Moderator
July 4, 2022
0

Approved and emerging CAR-Ts in multiple myeloma Hermann Einsele, MD, FRCP, University of Würzburg, Würzburg, Germany, comments on the efficacy and safety of idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel), two chimeric antigen receptor T-cell (CAR-T) therapies for multiple myeloma. Ide-cel has been approved by the FDA and EMA for patients with multiple myeloma who […]

Improving the management of multiple myeloma

By HealthClot Moderator
July 4, 2022
0

Improving the management of multiple myeloma Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, briefly explains the importance of accurate evaluation of patients with multiple myeloma. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.